top of page

Deployable, Domestic Manufacturing Technology for COVID-19 vaccine component

"BARDA, Snapdragon Chemistry INC., will collaborate to quickly develop an innovative and scalable continuous manufacturing platform for ribonucleotide triphosphates, a critical component for mRNA-based COVID-19 vaccines that use messenger RNA technology. The project includes a rapidly scalable, continuous manufacturing process for the chemical synthesis and purification of NTPs."

View the full press release.


138 views0 comments
bottom of page